Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohort

[1]  F. Clavel-Chapelon,et al.  Fruit and vegetable intake and the risk of gastric adenocarcinoma: A reanalysis of the european prospective investigation into cancer and nutrition (EPIC‐EURGAST) study after a longer follow‐up , 2012, International journal of cancer.

[2]  F. Clavel-Chapelon,et al.  Prostate stem‐cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: Results from the EPIC‐EURGAST study , 2012, International journal of cancer.

[3]  F. Mégraud,et al.  Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  E. Lahner,et al.  Micronutrients (Other than iron) and Helicobacter pylori Infection: A Systematic Review , 2012, Helicobacter.

[5]  F. Clavel-Chapelon,et al.  Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. , 2012, Carcinogenesis.

[6]  Gopal Jee Gopal,et al.  Vitamin-C as anti-Helicobacter pylori agent: More prophylactic than curative- Critical review , 2011, Indian journal of pharmacology.

[7]  F. Clavel-Chapelon,et al.  Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. , 2011, The American journal of clinical nutrition.

[8]  Paul C. D. Johnson,et al.  Genetic variation at the SLC23A1 locus is associated with circulating concentrations of L-ascorbic acid (vitamin C): evidence from 5 independent studies with >15,000 participants. , 2010, The American journal of clinical nutrition.

[9]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[10]  L. Cahill,et al.  Vitamin C Transporter Gene Polymorphisms, Dietary Vitamin C and Serum Ascorbic Acid , 2010, Lifestyle Genomics.

[11]  R. Peek,et al.  Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.

[12]  L. Hou,et al.  Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland. , 2009, European journal of cancer.

[13]  Alyce A. Chen,et al.  Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. , 2009, Carcinogenesis.

[14]  E. Halperin,et al.  Polymorphisms in the Estrogen Receptor 1 and Vitamin C and Matrix Metalloproteinase Gene Families Are Associated with Susceptibility to Lymphoma , 2008, PloS one.

[15]  S. Tsugane,et al.  Protective effect of vitamin C on oxidative stress: a randomized controlled trial. , 2008, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[16]  L. Avigliano,et al.  SVCT1 and SVCT2: key proteins for vitamin C uptake , 2008, Amino Acids.

[17]  N Slimani,et al.  The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study , 2007, European Journal of Clinical Nutrition.

[18]  S. Tsugane,et al.  Diet and the risk of gastric cancer: review of epidemiological evidence , 2007, Gastric Cancer.

[19]  F. Clavel-Chapelon,et al.  CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC‐EURGAST study , 2007, International journal of cancer.

[20]  Xavier Estivill,et al.  SNPassoc: an R package to perform whole genome association studies , 2007, Bioinform..

[21]  F. Clavel-Chapelon,et al.  Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST) , 2007, Scandinavian journal of gastroenterology.

[22]  F. Clavel-Chapelon,et al.  Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). , 2006, Carcinogenesis.

[23]  F Berrino,et al.  Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition , 2006, British Journal of Cancer.

[24]  F. Clavel-Chapelon,et al.  Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC–EURGAST) , 2006, International journal of cancer.

[25]  A. Olshan,et al.  Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. , 2006, American journal of epidemiology.

[26]  Elio Riboli,et al.  Long-term Cryoconservation and Stability of Vitamin C in Serum Samples of the European Prospective Investigation into Cancer and Nutrition , 2005, Cancer Epidemiology Biomarkers & Prevention.

[27]  S. Chanock,et al.  Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2 , 2004, Human Genetics.

[28]  F. Mégraud,et al.  Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics , 2003, British Journal of Cancer.

[29]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[30]  Taro Tokui,et al.  A family of mammalian Na+-dependent L-ascorbic acid transporters , 1999, Nature.

[31]  Hui-min Zhang,et al.  Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori , 1997, Cancer.

[32]  A. Axon,et al.  Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. , 1996, Carcinogenesis.

[33]  J. Vuilleumier,et al.  Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment , 1989 .

[34]  M. Blaser,et al.  Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.

[35]  S. Tannenbaum,et al.  Inhibition of nitrosamine formation by ascorbic acid. , 1991, The American journal of clinical nutrition.